TENEOTWO
TeneoTwo is a biotechnology firm that develops potential new medicine for B-cell haematologic malignancies, including diffuse large B-cell lymphoma and follicular lymphoma.
TeneoTwo is a biotechnology firm that develops potential new medicine for B-cell haematologic malignancies, including diffuse large B-cell lymphoma and follicular lymphoma.